Current enrolling clinical trials

Our clinical trials program is bringing the world’s best treatments to patients with eye diseases.

Current enrolling clinical trials

The Queensland Eye Institute is currently involved in recruitment of the following clinical trials:

AMBLYOPTICA

Protocol Number: SH03050
Phase: Investigational
Sponsor: Amblyoptica (Holding)
Information: Trial of the amblyoptica device for binocular treatment of amblyopia

DELTA

Protocol Number: IDEV-121-DELT
Phase: Investigational
Sponsor: Johnson & Johnson Surgical Vision
Information: Clinical handleability and acceptability assessment of the DELTA disposable delivery system

MER1

Protocol Number: NXGT-101-MER1
Phase: Investigational
Sponsor: Abbott Medical Optics
Information: Proof of concept study for next generation intraocular lens model MER001

OTX-TKI

Protocol Number: CLIN-Protocol-0046
Phase: I
Sponsor: Ocular Therapeutix
Information: A phase 1 open-label, dose escalation study of OTX-TKI (axitinib implant) for intravitreal use in subjects with neovascular age-related macular degeneration

TITAN

Protocol Number: IDEV-120-TTAN
Phase: Investigational
Sponsor: Johnson & Johnson Surgical Vision
Information: Clinical handleability and acceptability assessment of the TITAN modular cartridge delivery system